DIA Association News
Tomorrow's 21st Century Cures -- today
DIA Global SmartBrief | May 05, 2015
Last week, the U.S. House Energy & Commerce Committee released the second draft of the 21st Century Cures legislation to accelerate the discovery, development and delivery of next-generation health care products. Next month, you can really hit the accelerator by learning more about 21st Century Topics -- pediatric product development, pharmacovigilance and regulation of combination products in the 21st century, and more -- at our DIA 2015 51st Annual Meeting, June 14-18 in Washington, D.C. This is the last week you can make the Annual Meeting Advance Attendee List: Register online and use the content schedule to plan your agenda! You can also learn more about What Lies Ahead for 2015 through regional reports from the ASEAN, Australia, China, Europe, India and Africa/Middle East in our April 2015 Global Forum.
DIA's upcoming educational programs
DIA Global SmartBrief | Apr 30, 2015
The paths that drugs, medical devices and combination products travel into development and regulatory approval are converging like never before. Learn how you can not only survive but also thrive in such a dynamic environment, thanks to DIA's upcoming educational programs:
- A special Medical Devices, In Vitro Diagnostics and Combination Products track at our DIA 2015 51st Annual Meeting, June 14-18 in Washington, D.C.
- The New Medical Device Regulation Information Day, Sept. 22 in Vienna, Austria
- Drug and Device Combination Products -- Current Topics, Sept. 28-29 in Bethesda, Md.
- Companion Diagnostics, Sept. 30-Oct. 1 in Bethesda, Md.
DIA China 7th Annual Meeting
DIA Global SmartBrief | Apr 28, 2015
Experience one of the world's most essential and vibrant markets at our DIA China 7th Annual Meeting: Innovation and Convergence -- Building a Sustainable R&D Ecosystem, DIA's largest multidisciplinary educational and networking event in Asia, presented at Shanghai International Convention Center (SHICC) on May 24-27. Today is your last day to save through the early registration discount. Scheduled highlights of this year's program include:
- This year's CFDA Town Hall will give leading regulators the opportunity to communicate with the audience on hot topics related to drug review and approval system reform
- Breakthrough Therapies in Diabetes Diseases session
- Chronic HCV Management session
- Generic Drug Forum
- Special Forum: R&D Ecosystem
DIA works to globally advance the science of safety
DIA Global SmartBrief | Apr 23, 2015
Our new Drug Safety eLearning Program and Clinical Safety and Pharmacovigilance Accelerated Certificate Program overview safety regulations, requirements and attendant processes and procedures from clinical trials to approval to postmarketing activities. Prefer to learn in-person? Come join our:
- Premarketing Clinical Safety training course, May 18-19 in London, U.K.
- DIA Canadian Pharmacovigilance & Risk Management Meeting, May 21 in Toronto, Ontario
- 1st DIA Risk Management & Safety Communication Strategies Training Course in Japan, May 21-22 in Tokyo
DIA 2015 51st Annual Meeting
DIA Global SmartBrief | Apr 21, 2015
Our DIA 2015 51st Annual Meeting promises to shake things up: Keynote speaker Daniel Burrus (president and CEO, Burrus Research) is world famous as a leading futurist on global trends and innovation. Our program co-chairs represent the brightest leadership in health care product development: Christopher P. Austin, M.D. (director, National Center for Advancing Translational Sciences, National Institutes of Health) and Michael Rosenblatt, M.D. (executive vice president and chief medical officer, Merck & Co. Inc.). And at sessions such as Disruptive Forces in Health Care Innovation: Where Are They Leading Us?, expert panel discussion on the impact of hardware, wearable gadgets and new medical technologies on health care innovation and connecting patients to their care, will help you anticipate tomorrow's innovations today -- plus other hot topics, too. Register to join our DIA 2015 51st Annual Meeting, June 14-18, in Washington, D.C.
Risk-based monitoring sessions at DIA 2015
DIA Global SmartBrief | Apr 14, 2015
Stretching less into more has become a familiar refrain throughout the modern workplace, including clinical research sites. Learn how the emergence of Risk-Based Monitoring (RBM) can deliver the most benefit to your trials through monitoring targeted to areas of greatest risk, through these and other sessions at our upcoming DIA 2015 51st Annual Meeting: Develop, Innovate, Advance, June 14-18 in Washington, D.C.:
- Implementing Risk-Based Monitoring symposium, chaired by Willie Muehlhausen, DVM, head of innovation, ICON Clinical Research, Ireland
- How Risk-Based Monitoring and eSource Methodologies Are Impacting Clinical Sites, Patients, Regulators and Sponsors symposium, chaired by Jules T. Mitchel, Ph.D., MBA, president, Target Health Inc.
- TransCelerate Collaboration: Harmonization Efforts to Find Solutions to Critical Industry Challenges, chaired by Andy Lee, MA, senior vice president, head of global clinical trial operations, Merck & Co. Inc.
Special opportunity for government representatives
DIA Global SmartBrief | Apr 09, 2015
Information Day on ICH: Focus on the ICH Reform
8 a.m.-12:30 p.m. CET | April 13 | Paris, France
This year's Information Day will review the ICH reform following the key developments agreed to at the Steering Committee meeting in November 2014. Participants will also get the opportunity to hear directly from regulators and industry representatives about a selection of important new topics that are being addressed as part of the ICH process. Free registration for government representatives! Presented by DIA in collaboration with the European Commission (EC) and European Medicines Agency (EMA).
DIA 2015 51st Annual Meeting: Thursday program
DIA Global SmartBrief | Apr 07, 2015
Thursday's program at our DIA 2015 51st Annual Meeting: Develop, Innovate, Advance, being held June 14 to 18 in Washington, D.C., opens two unique opportunities to learn from regulatory leadership in the U.S. FDA and European Medicines Agency (EMA). First, listen to An Insider's View of Cooperation Between the EMA and CDER/FDA, which will focus on shared EMA and CDER perspectives on adaptive pathways, quality by design, patient involvement in medicine development and other topics; then, come to our annual CDER Town Hall, where CDER leadership will respond directly to audience questions. Read your digital preliminary program for more information, and register to join us in Washington, D.C.! Attendee list deadline is May 8. Register now to reserve your spot.